|
|
||||||||
Ann Thorac Surg 2007;83:108-114
© 2007 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, Heart Center Leipzig, Leipzig, Germany
b Department of Cardiology, Heart Center Leipzig, Leipzig, Germany
Accepted for publication August 14, 2006.
* Address correspondence to Dr Holzhey, Herzzentrum Leipzig, Strümpellstrasse 39, 04289 Leipzig, Germany (Email: dholzhey{at}web.de).
BACKGROUND: Minimally invasive direct coronary artery bypass (MIDCAB) for revascularization of the left anterior descending artery has become a routine operation. Here we present the experience after more than 1300 MIDCAB procedures with up to 7 years of follow-up.
METHODS: All patients undergoing standard MIDCAB between 1996 and 2004 were included. Long-term follow-up information about health status, major cardiac and cerebral adverse events, and freedom of angina was collected annually by a questionnaire or personal contact. Preoperative, intraoperative, and postoperative data could be completed for all 1347 patients. Five-year follow-up was available for 450 patients and 7-year follow-up for 194 patients.
RESULTS: Mean age was 63.2 years (range, 25 to 92 years) and mean ejection fraction was 0.61 ± 0.14. In 23 patients (1.7%), intraoperative conversion to sternotomy or CPB, or both, was necessary. Early postoperative mortality was 0.8% (n = 11), and 0.4% (n = 5) had a perioperative stroke. A routine postoperative angiogram in 709 patients showed 95.6% early graft patency. Short-term target vessel reintervention was needed 55 patients (4.1%): 10 had percutaneous transluminal coronary angioplasty/stent and 45 had reoperation. A repeat angiogram at the 6-month follow-up was available in 350 patients and demonstrated 94.3% graft patency. Kaplan-Meier analysis revealed a 5-year survival of 91.9% (95% confidence interval [CI], 90.1% to 93.8%) and a 7-year survival of 89.4% (95% CI, 86.7% to 92.1%). The freedom of major adverse events and angina was 89.5% (95% CI, 87.4% to 91.5%) after 5 years and 83.3% (95% CI, 79.0% to 87.5%) after 7 years.
CONCLUSIONS: MIDCAB can be safely performed with low postoperative mortality and morbidity. The excellent short-term and long-term survival as well as freedom from major adverse cardiac and cerebral events and angina compare favorably with stenting and conventional surgery.
This article has been cited by other articles:
![]() |
H. Thiele, P. Neumann-Schniedewind, S. Jacobs, E. Boudriot, T. Walther, F.-W. Mohr, G. Schuler, and V. Falk Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2324 - 2331. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Holzhey, S. Jacobs, M. Mochalski, D. Merk, T. Walther, F. W. Mohr, and V. Falk Minimally Invasive Hybrid Coronary Artery Revascularization Ann. Thorac. Surg., December 1, 2008; 86(6): 1856 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Becker, T. W. Meade, P. B. Berger, M. Ezekowitz, C. M. O'Connor, D. A. Vorchheimer, G. H. Guyatt, D. B. Mark, and R. A. Harrington The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 776S - 814S. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kappert, S.-M. Tugtekin, R. Cichon, M. Braun, and K. Matschke Robotic totally endoscopic coronary artery bypass: A word of caution implicated by a five-year follow-up. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 857 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Holzhey, S. Jacobs, T. Walther, M. Mochalski, F. W. Mohr, and V. Falk Cumulative sum failure analysis for eight surgeons performing minimally invasive direct coronary artery bypass J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 663 - 669. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |